Director at $RGS sells 500 shares in insider sale

A recent disclosure has revealed that MICHAEL J MERRIMAN, a director at $RGS, recently sold 500 shares of the company on December 17, 2025, for an estimated sum of $14,000. The information regarding this stock transaction was obtained from a recent filing with the Securities and Exchange Commission. This sale represents approximately 3.7% of their total shares of this class of stock, leaving them with 13,067 shares of $RGS stock in the same class.

Over the past six months, insiders at $RGS have engaged in stock transactions just once. Out of these transactions, there have been no purchases, only sales. Some of the recent insider trading activities involving $RGS stock include MICHAEL J MERRIMAN’s sale of 500 shares. To keep track of insider trades, interested parties can monitor Quiver Quantitative’s insider trading dashboard.

Regarding hedge fund activity related to $RGS, there have been notable movements by institutional investors in recent quarters. While some entities like WELLS FARGO & COMPANY/MN and KENT LAKE PR LLC removed all their shares from their portfolio, others like ASPIRE GROWTH PARTNERS LLC and MARSHALL WACE, LLP added significant amounts of $RGS stock to their holdings. For more detailed information on the stock portfolios of hedge funds, individuals can refer to Quiver Quantitative’s institutional holdings dashboard.

In terms of revenue, $RGS reported earnings of $59M in the first quarter of 2026, marking a 28.0% increase compared to the same period in the previous year. For those interested in monitoring the financial performance of $RGS, they can access related information on Quiver Quantitative’s RGS stock page.

It is essential to note that the content of this article does not constitute financial advice. Interested parties should review Quiver Quantitative’s disclaimers for additional information and guidance.